10Jan/13

Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to … – PharmaLive (press release) (subscription)

Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to
PharmaLive (press release) (subscription)
In addition, Proteo’s licensing and development partner, Minapharm Pharmaceuticals SAE, has initiated a Phase II clinical trial on the use of Elafin for kidney transplantation patients. This trial is concerned with the prevention of acute organ

and more »

10Jan/13

Texas Children's Hospital earns certification from the Centers for Medicare & Medicaid Services for all solid-organ …

HOUSTON, Jan. 10, 2013 /PRNewswire-USNewswire/ — Texas Children’s Hospital in Houston announced that it has recently earned a national certification from the Centers for Medicare & Medicaid Services (CMS) for heart, liver and lung transplants. Additionally, the hospital has been recertified by the agency for kidney transplants. For more information about Texas Children’s transplant program …